Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer
Abstract Background Indocyanine green (ICG) is becoming a frequently used sentinel lymph node (SLN) tracer of breast cancer in China. However, there is still a lack of data on its safety. We reported the clinical outcome of ICG as a tracer of SLN over a median 67-month follow-up period to evaluate i...
Main Authors: | Bin Hua, Yao Li, Xin Yang, Xiaotian Ren, Xu Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-022-02719-7 |
Similar Items
-
The Feasibility of Sentinel Lymph-Node, Mapped with Indocyanine Green, Biopsy in Endometrial Cancer Patients: A Prospective Study
by: Migle Gedgaudaite, et al.
Published: (2022-05-01) -
Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer
by: Joseph Lin, et al.
Published: (2020-12-01) -
Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer
by: Young Hwa Kwak, et al.
Published: (2022-03-01) -
Sentinel lymph node biopsy for breast cancer using indocyanine green fluorescence visualization
by: A. D. Zikiryakhodzhaev, et al.
Published: (2020-02-01) -
The feasibility and added value of indocyanine green tracing in guiding sentinel lymph node biopsy for breast cancer
by: Ercument Gurluler, et al.
Published: (2024-12-01)